pharmaceutical investing FDA Grants Rare Pediatric Disease Designation to A4250; Albireo Eligible to Apply for Priority Review Voucher
Silver Hammer Announces Uplisting to the OTCQB Venture Market in the United States, and Receives DTC Eligibility